HDLBP — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to HDLBP by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients	PHASE4	COMPLETED
Pilot HCV Direct Acting Antiviral Therapy and Metabolism	PHASE4	COMPLETED
The HDL Particle Protection Study	PHASE4	COMPLETED
Effect of Rosuvastatin Therapy on HDL2 Level	PHASE4	UNKNOWN
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes	PHASE3	COMPLETED
A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin	PHASE3	COMPLETED
Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults	PHASE2	COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides	PHASE1	COMPLETED
Molecular & Clinical Evaluation of Low HDL Syndromes	nan	COMPLETED
Epidemiology of Atherosclerosis	nan	COMPLETED
Improving Metabolism With HDL Cholesterol	nan	COMPLETED
The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk	nan	COMPLETED
The Roles of SAH Gene Family in Athrogenic Dyslipidemia in Postmenopausal Women	nan	UNKNOWN
Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders	nan	RECRUITING
HIV Reverse Cholesterol Transport Study	nan	UNKNOWN
High-Density Lipoprotein (HDL) Treatment Study	nan	COMPLETED
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects	nan	UNKNOWN
Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia	nan	COMPLETED
Apolipoprotein A-I Gene Polymorphism and Atherosclerosis	nan	COMPLETED
Genetic Epidemiology of Hypertriglyceridemia	nan	COMPLETED
Theobromine, Vascular Function and Intestinal apoA-I Production	nan	COMPLETED
HDL Function Dietary Supplement Safety and QOL	nan	UNKNOWN
Effect of Alcohol Consumption on Markers of Inflammation	nan	COMPLETED
Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia	nan	UNKNOWN
Hyperapo B and Coronary Heart Disease	nan	COMPLETED
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism	nan	ACTIVE_NOT_RECRUITING
Lipid Challenge in Adults	nan	COMPLETED
Paraoxonase and HDL Qualities in Glycaemia and Inflammation	nan	RECRUITING
Effect of Three Training Programs on the Cardiovascular Condition of Individuals with Spinal Cord Injury	nan	UNKNOWN
The Mixed Meal Challenge Study	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a HDLBP binder may also engage these)

Protein	Name	Similarity
Q9Z1A6	—	1.000	Q9Z1A6 →
Q8VDJ3	—	0.999	Q8VDJ3 →
P81021	—	0.998	P81021 →
Q5R439	—	0.998	Q5R439 →
O42254	—	0.973	O42254 →
Q5RB68	—	0.972	Q5RB68 →
Q8CGX0	—	0.972	Q8CGX0 →
Q5SF07	—	0.971	Q5SF07 →
IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	0.971	landscape →
O88477	—	0.971	O88477 →
Q5ZLP8	—	0.970	Q5ZLP8 →
Q9PW80	—	0.969	Q9PW80 →
Q08CK7	—	0.969	Q08CK7 →
IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	0.969	landscape →
Q9CPN8	—	0.968	Q9CPN8 →
O73932	—	0.968	O73932 →
IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	0.968	landscape →
O57526	—	0.966	O57526 →
Q5XI81	—	0.953	Q5XI81 →
Q9LZ82	—	0.953	Q9LZ82 →
F4HQD4	—	0.952	F4HQD4 →
Q9I8E6	—	0.952	Q9I8E6 →
Q9QZE5	—	0.951	Q9QZE5 →
P37142	—	0.951	P37142 →
Q9PUE4	—	0.951	Q9PUE4 →
Q9QXK3	—	0.950	Q9QXK3 →
A2RV18	—	0.950	A2RV18 →
C5DIR2	—	0.950	C5DIR2 →
USP7	Ubiquitin carboxyl-terminal hydrolase 7	0.950	landscape →
P27124	—	0.950	P27124 →